12 news items
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
AAN
AMCX
BIMI
17 Jun 24
in Dravet syndrome missed its primary endpoint
Kaival Brands Innovations Group, Inc
Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) at the European Hematology Association Congress (EHA2024)
NRIX
16 Jun 24
, development and commercialization of innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel
Nurix Therapeutics to Host a Webcast and Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of NX-5948 Being Presented at the European Hematology Association Congress (EHA2024)
NRIX
10 Jun 24
, development and commercialization of innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment
Nurix Therapeutics Appoints Paula G. O'Connor, M.D., as Chief Medical Officer and Pasit Phiasivongsa, Ph.D., as Chief Technical Officer
NRIX
28 May 24
biopharmaceutical company focused on the discovery, development and commercialization of innovative small molecules and antibody therapies based
Nurix Therapeutics Announces Board Chair Transition
NRIX
20 May 24
has been instrumental in our growth from a private, ligase research company to a public, drug discovery and development company with three innovative
q4itdrbqvcdrynym3w9f5mmi3pq1f70pvm0ne163vn 6od3ipf8qtduyms
NRIX
7 May 24
is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative small molecules and antibody
lfsbp4im
NRIX
16 Apr 24
of innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer
unhisu76f171 v3u5el
NRIX
11 Apr 24
of innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer
jhn hz7wn4pfz070cxw58y0ylmd5k7hv5pr2izeaouq3qiu6ed15p3
NRIX
11 Apr 24
biopharmaceutical company focused on the discovery, development and commercialization of innovative small molecules and antibody therapies based
5qg cn51m1ro3xqkwa
NRIX
9 Apr 24
, development and commercialization of innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel
oi87n3wv35 pdog5dt3civfqwpndcuw5
NRIX
2 Apr 24
focused on the discovery, development and commercialization of innovative small molecules and antibody therapies based on the modulation of cellular protein
5p6c8 yjf74vawj
NRIX
25 Mar 24
Research UK, whose goal is to facilitate identification of the greatest challenges in cancer today and to fund global teams to work in innovative ways
- Prev
- 1
- Next